Solutions
Advisory Services
Clinical Development
- Generics Development
- Clinical Operations
- Clinical Data Sciences
- Medical and Safety Services
- RWD & RWE Services
Post Marketing
- Safety Services
- Post marketing Studies
- Regulatory Affairs
Generative AI in clinical trials, a subset of Artificial Intelligence (AI), holds promise as clinical trials not only should be flexible and adaptable but also cost-effective, catering to the diverse needs of various stakeholder groups. The intricacies of clinical trials, inherently labor-intensive, complex, and heavily regulated, make this task pa...
Clinical Research Organizations (CROs) play a significant role in clinical research and in transforming healthcare. Ranging from catering to specialized niche pharmaceutical companies to expansive global pharma companies, CROs serve as the driving force behind the journey of new drugs and medical devices from conception to FDA approval. CRO’...
Clinical trials present a complex landscape that demands meticulous navigation through the intricacies of protocol development, regulatory compliance, and trial management—an inherently formidable task. It is in this intricate terrain that Contract Research Organizations (CROs) assume a pivotal role, emerging as indispensable partners for sp...
In this exciting blog, we focus on the research and innovation in rare disease clinical trials. Navitas Life Sciences’ commitment to accelerating pharmaceutical breakthroughs globally is reflected in our extensive experience of 600+ clinical trials, expertise in 20+ therapeutic areas, and a proven track record of collaborating with biopharma...
The World Health Organization states that nearly 39 million people live with HIV/AIDS globally (2022), with 630,000 people dying due to HIV related causes, necessitating the need for improved treatment and care. Navitas Life Sciences has been supporting the efficient management of clinical trials for small to large pharma and life sciences companie...
Dr Narendra Chirmule Director of Biological Sciences at Symphony Technology In this exciting blog, we have the privilege of hearing from a seasoned expert, Dr Narendra Chirmule, PhD who has dedicated decades to advancing our understanding of immunology and pushing the boundaries of drug development. Dr Chirmule is a Director of Biological Sciences ...
In our latest blog, Dr Philipp Hofmann, Director - Pharmacovigilance & QPPV, explores the significance of medication analysis, particularly for older patients in Germany. Offering a professional assessment, this analysis addresses crucial questions regarding potential adverse drug reactions and interactions. Dr Hofmann provides a comprehensive ...
In the ever-evolving landscape of Pharmacovigilance (PV), a parallel momentum is gaining traction — the imperative for transparency and heightened responsibility towards ensuring patient safety. Organizations operating in PV are now facing heightened pressure to demonstrate tangible progress. Transparency is the need of the hour. As we stand...
In a rapidly evolving clinical research landscape, decentralized clinical trials (DCTs) have emerged as a transformative approach, providing an efficient way to conduct clinical trials. To explore the unique capabilities at Navitas Life Sciences, we interviewed Dr Atul Gupta, Vice President – Medical Services and Client Solutions and Dr Akas...
Dr. Ayaaz Hussain Khan, Global Head of Generics at Navitas Life Sciences, will be a distinguished presence at CPHI 2023. With a wealth of experience and vast expertise, Dr. Khan will be present to find solutions for your unique needs and to provide a glimpse into the future of generics. In this blog, we spoke to Dr. Khan, to ask what CPHI North Bar...